vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and Porch Group, Inc. (PRCH). Click either name above to swap in a different company.

Porch Group, Inc. is the larger business by last-quarter revenue ($121.1M vs $77.6M, roughly 1.6× Bioceres Crop Solutions Corp.). Porch Group, Inc. runs the higher net margin — -3.9% vs -9.6%, a 5.7% gap on every dollar of revenue. On growth, Porch Group, Inc. posted the faster year-over-year revenue change (100.0% vs -16.8%). Over the past eight quarters, Porch Group, Inc.'s revenue compounded faster (26.4% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.

BIOX vs PRCH — Head-to-Head

Bigger by revenue
PRCH
PRCH
1.6× larger
PRCH
$121.1M
$77.6M
BIOX
Growing faster (revenue YoY)
PRCH
PRCH
+116.8% gap
PRCH
100.0%
-16.8%
BIOX
Higher net margin
PRCH
PRCH
5.7% more per $
PRCH
-3.9%
-9.6%
BIOX
Faster 2-yr revenue CAGR
PRCH
PRCH
Annualised
PRCH
26.4%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BIOX
BIOX
PRCH
PRCH
Revenue
$77.6M
$121.1M
Net Profit
$-7.4M
$-4.7M
Gross Margin
46.8%
52.7%
Operating Margin
9.3%
34.7%
Net Margin
-9.6%
-3.9%
Revenue YoY
-16.8%
100.0%
Net Profit YoY
-20.2%
2.0%
EPS (diluted)
$-0.12
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
PRCH
PRCH
Q1 26
$121.1M
Q4 25
$112.3M
Q3 25
$77.6M
$115.1M
Q2 25
$107.0M
Q1 25
$60.6M
$84.5M
Q4 24
$98.8M
$75.3M
Q3 24
$93.3M
$77.7M
Q2 24
$75.9M
Net Profit
BIOX
BIOX
PRCH
PRCH
Q1 26
$-4.7M
Q4 25
$-3.5M
Q3 25
$-7.4M
$-10.9M
Q2 25
$2.6M
Q1 25
$-1.6M
$8.4M
Q4 24
$605.2K
$30.5M
Q3 24
$-6.2M
$14.4M
Q2 24
$-64.3M
Gross Margin
BIOX
BIOX
PRCH
PRCH
Q1 26
52.7%
Q4 25
99.5%
Q3 25
46.8%
75.6%
Q2 25
70.9%
Q1 25
39.4%
77.4%
Q4 24
42.0%
Q3 24
40.2%
79.4%
Q2 24
22.1%
Operating Margin
BIOX
BIOX
PRCH
PRCH
Q1 26
34.7%
Q4 25
14.7%
Q3 25
9.3%
14.2%
Q2 25
4.7%
Q1 25
1.5%
-1.5%
Q4 24
14.5%
33.3%
Q3 24
2.5%
-3.2%
Q2 24
-69.2%
Net Margin
BIOX
BIOX
PRCH
PRCH
Q1 26
-3.9%
Q4 25
-3.1%
Q3 25
-9.6%
-9.4%
Q2 25
2.4%
Q1 25
-2.6%
9.9%
Q4 24
0.6%
40.5%
Q3 24
-6.6%
18.5%
Q2 24
-84.8%
EPS (diluted)
BIOX
BIOX
PRCH
PRCH
Q1 26
$-0.04
Q4 25
$0.00
Q3 25
$-0.12
$-0.10
Q2 25
$0.00
Q1 25
$-0.02
$0.07
Q4 24
$0.00
$0.34
Q3 24
$-0.10
$0.12
Q2 24
$-0.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
PRCH
PRCH
Cash + ST InvestmentsLiquidity on hand
$15.5M
$68.4M
Total DebtLower is stronger
$391.3M
Stockholders' EquityBook value
$288.3M
$26.3M
Total Assets
$734.9M
$806.6M
Debt / EquityLower = less leverage
14.87×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
PRCH
PRCH
Q1 26
$68.4M
Q4 25
$57.3M
Q3 25
$15.5M
$85.0M
Q2 25
$79.8M
Q1 25
$38.5M
$70.4M
Q4 24
$29.2M
$191.7M
Q3 24
$32.3M
$238.6M
Q2 24
$308.4M
Total Debt
BIOX
BIOX
PRCH
PRCH
Q1 26
$391.3M
Q4 25
$392.8M
Q3 25
$387.1M
Q2 25
$394.1M
Q1 25
$409.2M
Q4 24
$403.9M
Q3 24
$399.0M
Q2 24
$436.8M
Stockholders' Equity
BIOX
BIOX
PRCH
PRCH
Q1 26
$26.3M
Q4 25
$-24.6M
Q3 25
$288.3M
$-27.9M
Q2 25
$-29.3M
Q1 25
$345.0M
$-52.4M
Q4 24
$346.3M
$-43.2M
Q3 24
$346.0M
$-77.0M
Q2 24
$-101.9M
Total Assets
BIOX
BIOX
PRCH
PRCH
Q1 26
$806.6M
Q4 25
$797.4M
Q3 25
$734.9M
$787.7M
Q2 25
$770.7M
Q1 25
$798.2M
$802.3M
Q4 24
$835.2M
$814.0M
Q3 24
$827.3M
$867.3M
Q2 24
$876.1M
Debt / Equity
BIOX
BIOX
PRCH
PRCH
Q1 26
14.87×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
PRCH
PRCH
Operating Cash FlowLast quarter
$14.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
PRCH
PRCH
Q1 26
Q4 25
$1.2M
Q3 25
$14.4M
$40.8M
Q2 25
$35.6M
Q1 25
$23.3M
$-11.2M
Q4 24
$-5.4M
$-26.6M
Q3 24
$5.2M
$12.4M
Q2 24
$-26.0M
Free Cash Flow
BIOX
BIOX
PRCH
PRCH
Q1 26
Q4 25
$1.1M
Q3 25
$40.7M
Q2 25
$35.4M
Q1 25
$-11.2M
Q4 24
$-26.8M
Q3 24
$12.2M
Q2 24
$-26.0M
FCF Margin
BIOX
BIOX
PRCH
PRCH
Q1 26
Q4 25
1.0%
Q3 25
35.4%
Q2 25
33.0%
Q1 25
-13.3%
Q4 24
-35.6%
Q3 24
15.7%
Q2 24
-34.3%
Capex Intensity
BIOX
BIOX
PRCH
PRCH
Q1 26
Q4 25
0.1%
Q3 25
0.1%
Q2 25
0.2%
Q1 25
0.1%
Q4 24
0.3%
Q3 24
0.3%
Q2 24
0.1%
Cash Conversion
BIOX
BIOX
PRCH
PRCH
Q1 26
Q4 25
Q3 25
Q2 25
13.79×
Q1 25
-1.33×
Q4 24
-8.85×
-0.87×
Q3 24
0.86×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons